Results 291 to 300 of about 166,368 (358)

Maintenance therapy with oral decitabine plus cedazuridine after allogeneic stem cell transplantation for myelodysplastic syndrome. [PDF]

Haematologica
Smallbone P, Shigle TL, Paslovsky O, Hosing C, Alousi A, Bashir Q, Aljawai Y, Ramdial J, Popat U, Champlin R, Shpall EJ, Oran B.   +11 more
europepmc   +1 more source

DOCK8 deficiency presenting with sclerosing cholangitis, raised immunoglobulin E, and bronchiectasis: A fatal pediatric case report

JPGN Reports, EarlyView.
Abstract Dedicator of cytokinesis 8 (DOCK8) deficiency is a rare autosomal recessive primary immunodeficiency. Patients with DOCK8 deficiency typically present at early age with allergic manifestations, cutaneous and respiratory infections, raised immunoglobulin E, and they have an increased risk of developing malignancies.
Natalia Nedelkopoulou, Kelechi Ugonna, Stephen Hughes, Sanjay Rajwal, Marumbo Mtegha   +4 more
wiley   +1 more source

Feasibility of allogeneic stem cell transplantation (HSCT) in patients with acute myeloid leukemia previously treated with CPX-351: report from a single center. [PDF]

Ann Hematol
Giammarco S, Chiusolo P, Metafuni E, Limongiello MA, Sorà F, Frioni F, Di Marino L, Pagano L, Sica S.   +8 more
europepmc   +1 more source

Gastrointestinal manifestations following chimeric antigen receptor T‐cell (CAR‐T) 19 therapy in pediatric patients with CD19+ acute lymphoblastic leukemia

JPGN Reports, EarlyView.
Abstract Pediatric patients with CD19+ acute lymphoblastic leukemia (ALL) undergoing chimeric antigen receptor T‐cell (CAR‐T) therapy frequently experience gastrointestinal (GI) complications. A retrospective study analyzed 13 patients (median age: 8 years) treated between January 2020 and January 2024.
Judith Raya Muñoz, Melissa Panesso Romero, Saray Mesonero Cavia, Marta Freixas Bermejo, Vanessa Cabello Ruiz, Marina Álvarez Beltran, Maria Cristina Díaz de Heredia Rubio, Susana Elena Redecillas Ferreiro, Oscar Segarra Canton   +8 more
wiley   +1 more source

Corrigendum: Efficacy and survival outcome of allogeneic stem-cell transplantation in multiple myeloma: meta-analysis in the recent 10 years. [PDF]

Front Oncol
Lin SY, Lu KJ, Zheng XN, Hou J, Liu TT.
europepmc   +1 more source

Phosphatidylinositol 3-Kinase Inhibition and Allogeneic Stem Cell Transplantation Can Overcome Chemotherapy Resistance in Refractory Burkitt Lymphoma. [PDF]

J Hematol
Wirk B, Jayakumar R, Lim J.
europepmc   +1 more source

The Changing Role of Allogeneic Stem Cell Transplantation in Adult B-ALL in the Era of CAR T Cell Therapy. [PDF]

Curr Oncol
van den Berg J, Meloni C, Halter J, Passweg JR, Holbro A.   +4 more
europepmc   +1 more source

Prior status of graft-versus-host disease affects donor lymphocyte infusion outcomes in patients with relapsed haematological malignancies after allogeneic stem cell transplantation. [PDF]

Br J Haematol
Velasco CM, Inoue Y, Cioccio J, Rakszawski K, Songdej N, Nickolich M, Zheng H, Naik S, Ehmann C, Mierski J, Silar B, Vajdic C, Greiner R, Brown V, Mineishi S, Shike H, Minagawa K.   +16 more
europepmc   +1 more source

Pretransplant MRD does not seem to affect survival in NPM1-mutated AML undergoing allogeneic stem cell transplantation. [PDF]

Blood Adv
Fraccaroli A, Jurinovic V, Hirschbühl K, Stauffer E, Koch K, Breitkopf S, Haebe S, Drolle H, Rothenberg-Thurley M, Dufour A, Metzeler KH, Spiekermann K, Hentrich M, Hausmann A, Verbeek M, Schmid C, Herold T, Tischer J.   +17 more
europepmc   +1 more source

Dendritic Cells of Leukemic Origin (DC_leu) Modulate the Expression of Inhibitory Checkpoint Molecules and Their Ligands on T Cells and Blasts in AML Relapse After Allogeneic Stem Cell Transplantation. [PDF]

Cancers (Basel)
Feng X, Filippini Velázquez G, Bohlscheid S, Unterfrauner M, Anand P, Rejeski HA, Hartz A, Baudrexler T, Schmid C, Schmetzer HM.   +9 more
europepmc   +1 more source